News
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( NVO -7.70%) and Viking Therapeutics ( VKTX -0.97%), are falling 7.1% and 1.7%, respectively.
StockStory.org on MSN1h
Why Is Eli Lilly (LLY) Stock Rocketing Higher TodayWhat Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 15.3% in the morning session after results ...
But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...
We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...
U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
President Trump unveiled a wide-ranging executive order that aims to lower drug prices, boost transparency into fees charged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback